This study aims to present the first graded prognostic assessment (GPA) for small cell lung cancer (SCLC) and to examine the impact of PD-L1 on survival rates in non-small cell lung cancer (NSCLC), while also updating the existing Lung GPA based on new findings.
The analysis was conducted on a large group of 4,183 lung cancer patients with brain metastases, identifying key prognostic factors that influence survival across different types of lung cancer.
Results indicated varying median survival rates based on the type of lung cancer and GPA, with significant findings showing that PD-L1 expression is a predictive factor for survival, particularly in lung adenocarcinoma patients.